Time for a
Extended-release exenatide (Bydureon BCise), given weekly, uses a microsphere suspension that may cause more injection site nodules (reported in 10.5% of patients according to its FDA label) compared to solution-based formulations
The MHRA maintains a comprehensive database of approved medications, including all brand and generic names, to support safe medication use across the NHS and private healthcare sectors
European journal of endocrinology , 139 (5), 552561
Can DPP-4 (Dipeptidyl Peptidase-4) inhibitors be used with GLP-1 (Glucagon-Like Peptide-1) receptor agonists in type 2 diabetes treatment?
doi: 10.1097/PAS.0000000000001362 Summary Keywords melanoma, melanocytoma, dysplastic nevus, clinicopathological correlation, histopathology, immunohistochemistry, molecular biology Citation Ferrara G and Argenziano G (2021) The WHO 2018 Classification of Cutaneous Melanocytic Neoplasms: Suggestions From Routine Practice